Sitwat Ali

Conflicts of Interest Rachel E. Neale has received funding from Viatris for an unrelated project. Joel Rhee has received honoraria from Merck Sharpe & Dohme, Pfizer and AstraZeneca for providing advice, chairing and presenting at clinician educational events. Christopher Baggoley sits on the boards of Pankind, Calvary and FCD.

Introduction Pancreatic cancer is the seventh leading cause of cancer-related fatalities globally.1 In more developed regions, it is predicted to advance from the fourth to the second most common cause of cancer-related deaths by the year 2030.1, 2 Survival from pancreatic cancer is strongly related to stage at diagnosis, with 5-year survival for localized and metastatic disease being 44% and 3%, respectively.3, 4 Screening to detect disease earlier may improve outcomes, but due to the low...

Clinical Trial Summary Background Vitamin D may play a role in prevention of keratinocyte cancer (KC), but observational studies examining the association between serum 25-hydroxy vitamin D concentration and KC are largely uninformative because sun exposure causes both KC and vitamin D production. There is scant evidence from clinical trials of supplementary vitamin D. Objectives To examine the effect of vitamin D supplementation on the risk of developing KC.